John Ravits, MD - Improving Outcomes in ALS Through Early Diagnosis and Emerging Targeted Therapies

Go online to PeerView.com/XVB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in neurology discusses early diagnosis and emerging targeted therapies in the treatment of patients with amyotrophic lateral sclerosis (ALS). Upon completion of this activity, participants should be better able to: Apply established criteria to detect and diagnose patients with amyotrophic lateral sclerosis (ALS) early in the disease course, Recognize common genetic mutations that can cause ALS in patients with and without a family history of ALS, Assess key data sets on the efficacy, safety, and tolerability of available and emerging therapies for the treatment of ALS, Identify the potential impact of emerging therapies on the future management of genetic subtypes of ALS.